Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:03:28.973Z.
Calculation as of: 2026-10-06T16:03:28.973Z.
Quote observation: 2026-10-06T15:59:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5055be797218969f54b4ba6f74251721a3824cc5143f897fa443291008c6f72f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$67.38M
Operating Cash Flow Yield
N/A
TTM Avg
6.78%
3Y Avg
5.38%
5Y Avg
6.29%
Market Cap
$68.43M
Operating Cash Flow Yield
184.01%
TTM Avg
137.45%
3Y Avg
137.45%
5Y Avg
137.45%
Market Cap
$70.25M
Operating Cash Flow Yield
N/A
TTM Avg
0.41%
3Y Avg
0.41%
5Y Avg
0.41%
Market Cap
$64.71M
Operating Cash Flow Yield
N/A
TTM Avg
2.92%
3Y Avg
2.92%
5Y Avg
2.92%
Market Cap
$63.78M
Operating Cash Flow Yield
N/A
TTM Avg
3.39%
3Y Avg
3.39%
5Y Avg
3.39%
Market Cap
$63.69M
Operating Cash Flow Yield
N/A
TTM Avg
76.71%
3Y Avg
76.71%
5Y Avg
76.71%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iBio, Inc. (IBIO) | $68.17M | N/A | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $67.38M | N/A | 6.78% | 5.38% | 6.29% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.43M | 184.01% | 137.45% | 137.45% | 137.45% |
| RenovoRx, Inc. (RNXT)vs › | $66.45M | N/A | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $70.25M | N/A | 0.41% | 0.41% | 0.41% |
| Cingulate Inc. (CING)vs › | $66.00M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $64.71M | N/A | 2.92% | 2.92% | 2.92% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | N/A | 3.39% | 3.39% | 3.39% |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.69M | N/A | 76.71% | 76.71% | 76.71% |
| InterCure Ltd. (INCR)vs › | $63.61M | 14.82% | 19.10% | 19.10% | 6.56% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
